Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | CDC25B | P30305 | 2/20 | 0.61 |
| ▸ | CDC25A | P30304 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | ATM | Q13315 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15793780 | 1.00 | AKR1C3 (0.71) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL6056968 | 1.00 | AKR1C3 (0.71) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL30549431 | 1.00 | AKR1C3 (0.71) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL7821719 | 0.89 | KDM4E (0.63) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL8380031 | 0.88 | KDM4E (0.58) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL8380475 | 0.88 | KDM4E (0.58) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL8785619 | 0.87 | KDM4E (0.61) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL8784827 | 0.87 | KDM4E (0.61) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL28486818 | 0.87 | CYP2C8 (0.56) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B | |
| SCHEMBL7822787 | 0.86 | CYP2C8 (0.64) | AKR1C3KDM4ECYP2C8CYP2C9CDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1722376-A1 | ELECTROACTIVE POLYMER AND MATERIAL BASED THEREON | Koltsova, Anastasia Adrianovna (RU) | 2006-11-15 | — | — | EP | claimed |
| EP-1722376-A1 | ELECTROACTIVE POLYMER AND MATERIAL BASED THEREON | Koltsova, Anastasia Adrianovna (RU) | 2006-11-15 | — | — | EP | disclosed |
| EP-1433211-B1 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES CO (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20050288522-A1 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY | 2005-12-29 | — | — | US | disclosed |
| US-6974877-B2 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-12-13 | — | — | US | disclosed |
| CN-1592729-A | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES CO (US) | 2005-03-09 | — | — | CN | disclosed |
| US-6864396-B2 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-08 | — | — | US | disclosed |
| CN-1582506-A | Substituted pentacene semiconductors | 3M INNOVATIVE PROPERTIES CO (US) | 2005-02-16 | — | — | CN | disclosed |
| EP-1430008-A2 | PROCESS FOR PREPARING PENTACENE DERIVATIVES | 3M Innovative Properties Company (US) | 2004-06-23 | — | — | EP | disclosed |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY | 2003-06-05 | — | — | US | disclosed |
| US-20030100779-A1 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-29 | — | — | US | disclosed |
| US-20030097010-A1 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-22 | — | — | US | disclosed |
| WO-2003027050-A2 | PROCESS FOR PREPARING PENTACENE DERIVATIVES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-04-03 | — | — | WO | disclosed |
| US-4417059-A | COLOR FORMERS FOR CARBONLESS DUPLICATING AND THERMAL MARKING | STERLING DRUG INC. (US) | 1983-11-22 | — | — | US | disclosed |
| US-4343493-A | LEUCO DYES; CARBON-FREE; PRESSURE SENSITIVE ELEMENTS; THERMOSENSITIVITY | STERLING DRUG INC. (US) | 1982-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288522-A1 | Process for preparing pentacene derivatives | RARA, RARB, C9 | AKR1C3 507/4885KDM4E 2446/4885CYP2C8 1284/4885 |
| US-20030097010-A1 | Process for preparing pentacene derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PCBP1, RARA | AKR1C3 718/4885KDM4E 3301/4885CYP2C8 131/4885 |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | ETV1, HTR3C, SLC43A1 | AKR1C3 802/4885KDM4E 357/4885CYP2C8 292/4885 |
| US-20030100779-A1 | Process for preparing pentacene derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PCBP1, RARA | AKR1C3 718/4885KDM4E 3301/4885CYP2C8 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.